` 6609 (Shanghai HeartCare Medical Technology Corp Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

6609
vs
Hang Seng (Hong Kong)

Over the past 12 months, has significantly outperformed Hang Seng (Hong Kong), delivering a return of 63% compared to the Hang Seng (Hong Kong)'s 30% growth.

Stocks Performance
6609 vs Hang Seng (Hong Kong)

Loading
6609
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com

Performance Gap
6609 vs Hang Seng (Hong Kong)

Loading
6609
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
6609 vs Hang Seng (Hong Kong)

Loading
6609
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
Shanghai HeartCare Medical Technology Corp Ltd vs Peers

Hang Seng (Hong Kong)
6609
ABT
ISRG
BSX
SYK
Add Stock

Shanghai HeartCare Medical Technology Corp Ltd
Glance View

Market Cap
1.1B HKD
Industry
Health Care

Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-08-20. The firm's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The firm's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The firm's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The firm distributes its products within the domestic market.

Intrinsic Value
26.61 HKD
Overvaluation 3%
Intrinsic Value
Price
Back to Top